BDBM683753 6-(6-chloro-4-{3,9-diazabicyclo[4.2.1]nonan-3-yl}-8-fluoro-2-{[(2S)-1-methylpyrrolidin-2-yl]methoxy}quinazolin-7-yl)-4-methyl-5-(trifluoromethyl)pyridin-2-amine::US20240217982, Example 2-1

SMILES CN1CCC[C@H]1COc1nc(N2CCC3CCC(C2)N3)c2cc(Cl)c(c(F)c2n1)-c1nc(N)cc(C)c1C(F)(F)F

InChI Key InChIKey=PJFLMJYRBNHFFS-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 683753   

TargetGTPase KRas [G12D](Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM683753(US20240217982, Example 2-1 | 6-(6-chloro-4-{3,9-di...)
Affinity DataIC50: 40nMAssay Description:Recombinant GDP-loaded KRAS G12D (20 nM) was treated with compound at room temperature for 20 minutes in assay buffer (10 mM Hepes pH 7.4, 150 mM NaC...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent